Laboratory Corporation of... (LH)
undefined
undefined%
At close: undefined
232.00
1.05%
Pre-market Jan 07, 2025, 04:03 AM EST

Laboratory Corporation of America Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
LabCorp Diagnostics Revenue 2.55B 2.52B 2.48B 9.42B 2.34B 2.34B 2.38B 9.20B 1.41B 1.45B 1.46B 10.36B 1.46B 1.50B 1.44B 9.25B 1.24B 1.09B 1.14B 2.34B 1.18B 1.13B 1.07B 2.19B 1.08B 1.05B 1.08B 6.07B 761.10M 699.70M 690.30M 5.69B 701.10M 722.40M 704.60M 4.61B 2.28B 1.59B 300.30M 5.68B 1.47B 1.43B 1.35B 5.47B 1.38B 1.38B
LabCorp Diagnostics Revenue Growth +1.13% +1.82% -73.66% +301.55% +0.17% -1.76% -74.11% +554.68% -3.18% -0.51% -85.92% +610.08% -2.39% +3.96% -84.46% +645.10% +13.55% -4.38% -51.16% +99.23% +4.36% +4.80% -50.92% +102.47% +2.59% -2.25% -82.25% +698.11% +8.78% +1.36% -87.86% +711.33% -2.95% +2.53% -84.73% +102.14% +43.73% +428.70% -94.72% +286.83% +2.63% +6.00% -75.29% +296.66% -0.28% n/a
Covance Drug Development Revenue 737.70M 707.00M 710.90M 2.77B 719.10M 699.00M 1.40B 5.71B 2.21B 2.26B 2.45B 5.85B 2.62B 2.37B 2.76B 4.88B 2.70B 1.69B 1.70B 6.66B 1.76B 1.76B 1.72B 6.66B 1.75B 1.81B 1.77B 14.34B 1.84B 1.80B 1.72B 13.19B 1.67B 1.66B 1.59B 12.40B 6.25B 4.62B 1.47B 329.40M 82.90M 85.10M 80.40M 343.10M 81.70M n/a
Covance Drug Development Revenue Growth +4.34% -0.55% -74.37% +285.79% +2.88% -50.12% -75.46% +158.66% -2.12% -8.10% -58.02% +123.32% +10.65% -14.23% -43.46% +80.37% +59.76% -0.55% -74.45% +278.73% -0.10% +2.26% -74.16% +280.38% -3.42% +2.47% -87.66% +680.59% +2.12% +4.73% -86.97% +688.84% +0.73% +4.34% -87.17% +98.42% +35.20% +213.99% +346.87% +297.35% -2.59% +5.85% -76.57% +319.95% n/a n/a

Revenue by Geography

Quarter Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Europe Revenue 2.05B 1.51B 1.20B 1.18B 857.70M
Europe Revenue Growth +35.62% +26.05% +1.55% +37.74% n/a
North America Revenue 13.09B 11.53B n/a n/a n/a
North America Revenue Growth +13.61% n/a n/a n/a n/a
Other Countries Revenue 976.40M 941.00M n/a n/a n/a
Other Countries Revenue Growth +3.76% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 568.60M 557.80M 508.40M 532.90M 525.50M 505.80M 553.60M 536.50M 510.00M 486.00M 464.10M 543.70M 519.90M 458.70M 429.80M 518.00M 419.50M 396.30M 395.50M 413.90M 401.50M 415.30M 393.80M 396.90M 381.80M 395.20M 397.00M 492.40M 465.30M 435.30M 419.40M 406.00M 400.50M 408.00M 411.90M 404.90M 382.50M 392.40M 415.10M
Selling, General, and Administrative Revenue Growth +1.94% +9.72% -4.60% +1.41% +3.89% -8.63% +3.19% +5.20% +4.94% +4.72% -14.64% +4.58% +13.34% +6.72% -17.03% +23.48% +5.85% +0.20% -4.45% +3.09% -3.32% +5.46% -0.78% +3.95% -3.39% -0.45% -19.37% +5.82% +6.89% +3.79% +3.30% +1.37% -1.84% -0.95% +1.73% +5.86% -2.52% -5.47% n/a
Research and Development Revenue n/a n/a n/a 2.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a